Tenofovir alafenamide Fumarate: clinical trials recruiting now

Fewer than 3 recruiting trials found.

Phase breakdown

Conditions being studied

Recruiting trials involving Tenofovir alafenamide Fumarate

• Nucleoside (Acid) Analogues Treatment in Patients With Normal ALT and Positive HBVDNA.
  NCT04231565 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• TAF (Tenofovir Alafenamide) for Preventing Progression of Liver Disease in Non-cirrhotic Chronic HBV Infection With Normal ALT and Low Viral Load.
  NCT05195450 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location

Common questions

How many recruiting trials involve Tenofovir alafenamide Fumarate?

2 recruiting trials across 3 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.